Atriomx Health, a Menlo Park, California -based developer of novel, non-invasive solutions for the detection and characterization of the underlying disease mechanisms of atrial fibrillation and other arrhythmias, announced today that it has secured a $10 million Series A financing. Ajax Health and Zeus Health will co-lead t
December 22, 2020
· 1 min read